Martini Jeffrey S reported option exercise involving 6,250 derivative units of PALVELLA THERAPEUTICS, INC. at $0.00 for $0 on Nov 11, 2026

Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
Chief Scientific Officer
Chief Scientific Officer
Filed Nov 12, 2026

Facts from the filing

Form 4 · Derivative, table II
Disclosed value
$0Shares × reported price
Shares traded
6,250Stock Option (Right to Buy)
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
20,520Direct
Trade date
Nov 11, 2026Option exercise
Filed
Nov 12, 2026, 6:54 PM ET1-day reporting delay
Accession
0001104659-26-126376Code M · Transaction 399876
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Nov 10, 2026Option exercise4,266$7.53$32,122.98Trade 399858
Nov 10, 2026Option exercise1,984$9.79$19,423.36Trade 399859
Nov 11, 2026Option exercise6,250$9.79$61,187.50Trade 399867
Nov 10, 2026Sell100$163.34−$16,333.53Trade 399860
Nov 10, 2026Sell1,449$164.85−$238,871.13Trade 399861
Nov 10, 2026Sell1,651$165.85−$273,813.73Trade 399862
Nov 10, 2026Sell1,500$166.91−$250,369.05Trade 399863
Nov 10, 2026Sell200$167.81−$33,562Trade 399864
Nov 10, 2026Sell550$169.03−$92,964.52Trade 399865
Nov 10, 2026Sell800$172.12−$137,695.04Trade 399866
Nov 11, 2026Sell1,650$164.14−$270,834.63Trade 399868
Nov 11, 2026Sell1,467$165.78−$243,195.74Trade 399869
Nov 11, 2026Sell1,133$166.76−$188,942.03Trade 399870
Nov 11, 2026Sell1,200$167.75−$201,298.56Trade 399871
Nov 11, 2026Sell600$168.73−$101,239.98Trade 399872
Nov 11, 2026Sell200$169.78−$33,956.44Trade 399873
Nov 10, 2026Option exercise4,266$0.00$0Trade 399874
Nov 10, 2026Option exercise1,984$0.00$0Trade 399875
19 transaction rows in this filing. Joint filers share the same rows.

PVLA price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
PVLA · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 19, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago −12%1w ago +5.9%1d ago +10%
Returns since7d30d90d180d1y

Footnotes in full

F1: The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on July 13, 2026. The plan was adopted during an open trading window, at a time when the Reporting Person was not in possession of material non-public information and was reviewed and approved in accordance with the Issuer's Insider Trading Policy. The Issuer's officers and directors from time to time utilize trading plans to transact in its securities for reasons such as satisfying vesting-related income tax requirements, investment diversification, or other personal reasons. F2: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $163.12 to $163.37, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. F3: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $164.42 to $165.41, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. F4: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $165.62 to $166.30, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. F5: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $166.63 to $167.39, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. F6: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $168.82 to $169.25, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. F7: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $171.83 to $172.40, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. F8: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $163.77 to $164.67, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. F9: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $165.25 to $166.24, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. F10: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $166.25 to $167.20, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. F11: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $167.32 to $168.29, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. F12: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $168.48 to $169.47, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. F13: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $169.49 to $169.83, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. F14: The stock option vests in equal monthly installments over a forty-eight month period. The option was granted on May 28, 2024. F15: The stock option vests in equal monthly installments over a forty-eight month period. The option was granted on February 23, 2023.